DK277780A - Fremgangsmaade til fremstilling af tetra- eller pentapeptider - Google Patents

Fremgangsmaade til fremstilling af tetra- eller pentapeptider

Info

Publication number
DK277780A
DK277780A DK277780A DK277780A DK277780A DK 277780 A DK277780 A DK 277780A DK 277780 A DK277780 A DK 277780A DK 277780 A DK277780 A DK 277780A DK 277780 A DK277780 A DK 277780A
Authority
DK
Denmark
Prior art keywords
pentapeptides
procedure
preparing tetra
tetra
preparing
Prior art date
Application number
DK277780A
Other languages
English (en)
Other versions
DK154940B (da
DK154940C (da
Inventor
J Bouchaudon
D Farge
C James
Original Assignee
Rhone Poulenc Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Ind filed Critical Rhone Poulenc Ind
Publication of DK277780A publication Critical patent/DK277780A/da
Publication of DK154940B publication Critical patent/DK154940B/da
Application granted granted Critical
Publication of DK154940C publication Critical patent/DK154940C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK277780A 1979-06-29 1980-06-27 Analogifremgangsmaade til fremstilling af tetra- eller pentapeptider DK154940C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7916845 1979-06-29
FR7916845A FR2460290A1 (fr) 1979-06-29 1979-06-29 Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent

Publications (3)

Publication Number Publication Date
DK277780A true DK277780A (da) 1980-12-30
DK154940B DK154940B (da) 1989-01-09
DK154940C DK154940C (da) 1989-05-29

Family

ID=9227279

Family Applications (1)

Application Number Title Priority Date Filing Date
DK277780A DK154940C (da) 1979-06-29 1980-06-27 Analogifremgangsmaade til fremstilling af tetra- eller pentapeptider

Country Status (16)

Country Link
US (1) US4742048A (da)
JP (1) JPS5636440A (da)
AU (1) AU544863B2 (da)
BE (1) BE884077A (da)
CH (1) CH651577A5 (da)
DE (1) DE3024281A1 (da)
DK (1) DK154940C (da)
FR (1) FR2460290A1 (da)
GB (1) GB2053231B (da)
IE (1) IE51058B1 (da)
IT (1) IT1131395B (da)
LU (1) LU82567A1 (da)
NL (1) NL8003762A (da)
NZ (1) NZ194179A (da)
SE (1) SE448302B (da)
ZA (1) ZA803887B (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK156252B (da) * 1979-07-31 1989-07-17 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4458078A (en) * 1978-11-14 1984-07-03 Fujisawa Pharmaceutical Company, Ltd. Oxazole derivatives
US4749691A (en) * 1978-11-14 1988-06-07 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4539155A (en) * 1978-11-14 1985-09-03 Fuisawa Pharmaceutical Company, Ltd. New peptide, process for preparation thereof and use thereof
US4725582A (en) * 1978-11-14 1988-02-16 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
US4354966A (en) 1978-11-14 1982-10-19 Fujisawa Pharmaceutical Co., Ltd. Peptides, process for preparation thereof and use thereof
US4801580A (en) * 1978-11-14 1989-01-31 Fujisawa Pharmaceutical Company, Ltd. Peptide, process for preparation thereof and use thereof
JPS5645449A (en) * 1979-07-31 1981-04-25 Fujisawa Pharmaceut Co Ltd Novel peptide, its pharmaceutically acceptable salt and preparation of the same
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them
JPS57114556A (en) * 1980-10-27 1982-07-16 Fujisawa Pharmaceut Co Ltd Novel peptide compound and its preparation
IE51684B1 (en) * 1980-10-27 1987-02-04 Fujisawa Pharmaceutical Co Peptides,process for their preparation and pharmaceutical compositions containing them
DK465681A (da) * 1980-11-11 1982-05-12 Fujisawa Pharmacetical Co Ltd Fremgangsmaade til fremstilling af peptidderivater
GR81332B (da) * 1980-12-01 1984-12-11 Fujisawa Pharmaceutical Co
US4497729A (en) * 1980-12-01 1985-02-05 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
FR2496654A1 (fr) * 1980-12-19 1982-06-25 Rhone Poulenc Sante Nouveaux tri-, tetra- et pentapeptides, leur preparation et les medicaments qui les contiennent
US4493794A (en) * 1980-12-31 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
US4399066A (en) 1981-01-29 1983-08-16 Fujisawa Pharmaceutical Co., Ltd. Novel peptide, process for preparation thereof and use thereof
JPH068312B2 (ja) * 1981-01-29 1994-02-02 藤沢薬品工業株式会社 新規ペプチドの製造法
GR77929B (da) 1981-01-29 1984-09-25 Fujisawa Pharmaceutical Co
GR79114B (da) * 1981-01-29 1984-10-02 Fujisawa Pharmaceutical Co
US4504471A (en) * 1982-09-27 1985-03-12 Fujisawa Pharmaceutical Co., Ltd. Animal growth promotant and method of use for animal growth
EP0114787B1 (de) * 1983-01-25 1991-09-25 Ciba-Geigy Ag Neue Peptidderivate
NZ229004A (en) * 1988-05-19 1993-09-27 Immunobiology Res Inst Inc Tetrapeptides having t cell helper acitivity
WO1990003180A1 (en) * 1988-09-30 1990-04-05 Immunobiology Research Institute, Inc. Peptides having t cell suppressor activity
US5036050A (en) * 1989-01-12 1991-07-30 Immunobiology Research Institute, Inc. Compositions containing thymopentin for topical treatment of skin disorders
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5312831A (en) * 1993-05-12 1994-05-17 American Cyanamid Company Urethanes and ureas that induce cytokine production
AU6834194A (en) * 1993-05-14 1994-12-12 Mallinckrodt Medical, Inc. Ligand precursors for incorporation into peptides
AUPO161196A0 (en) * 1996-08-13 1996-09-05 Commonwealth Scientific And Industrial Research Organisation Novel compounds
ATE225511T1 (de) * 1997-12-11 2002-10-15 Roche Diagnostics Gmbh Entstörung von diagnostischen verfahren durch peptide aus d-aminosäuren
WO2001046127A1 (fr) * 1999-12-22 2001-06-28 Om Pharma Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise
EP3323424A1 (en) 2016-11-17 2018-05-23 Cyanimal IP Cyaa polypeptides as immune enhancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442889A1 (fr) * 1978-10-19 1980-06-27 Anvar Nouveaux composes hydrosolubles provenant d'extraits de streptomyces stimulosus, leur obtention, leur application a titre d'adjuvants immunologiques et compositions les contenant
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
US4311640A (en) * 1978-11-14 1982-01-19 Fujisawa Pharmaceutical Co., Ltd. Peptide, process for preparation thereof and use thereof
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
US4335111A (en) * 1978-12-22 1982-06-15 Agence National De Valorisation De La Recherche (Anvar) Compounds associating peptidyl of aminoacyl residues to lipophilic groups and pharmaceutical compositions containing said new compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK156252B (da) * 1979-07-31 1989-07-17 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf

Also Published As

Publication number Publication date
BE884077A (fr) 1980-12-29
IT1131395B (it) 1986-06-18
ZA803887B (en) 1981-07-29
NZ194179A (en) 1983-11-18
DK154940B (da) 1989-01-09
AU544863B2 (en) 1985-06-20
FR2460290A1 (fr) 1981-01-23
AU5970080A (en) 1981-01-08
IE801342L (en) 1980-12-29
DE3024281A1 (de) 1981-01-08
SE448302B (sv) 1987-02-09
GB2053231B (en) 1983-09-07
DK154940C (da) 1989-05-29
US4742048A (en) 1988-05-03
GB2053231A (en) 1981-02-04
SE8004792L (sv) 1980-12-30
CH651577A5 (fr) 1985-09-30
FR2460290B1 (da) 1983-12-16
LU82567A1 (fr) 1981-02-03
NL8003762A (nl) 1980-12-31
JPS5636440A (en) 1981-04-09
IE51058B1 (en) 1986-09-17
JPH0159276B2 (da) 1989-12-15
IT8023072A0 (it) 1980-06-26

Similar Documents

Publication Publication Date Title
DK277780A (da) Fremgangsmaade til fremstilling af tetra- eller pentapeptider
DK157019C (da) Analogifremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK147225C (da) Fremgangsmaade til fremstilling af intravenoest indgivelige immunogammaglobulinderivater
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK294880A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK222180A (da) Fremgangsmaade til fremstilling af 3-thiovinylcephalosporiner
DK151252C (da) Analogifremgangsmaade til fremstilling af 3-alkyltio-4-oxoquinolinforbindelser
DK413780A (da) Fremgangsmaade til fremstilling af d-6-n-propylergoliner
DK54280A (da) Fremgangsmaade til fremstilling af heterotricykliske derivater
DK228080A (da) Fremgangsmaade til fremstilling af saccharosemonoestere
DK205580A (da) Fremgangsmaade til fremstilling af benzodiazepinderivater
ES496787A0 (es) Procedimiento de preparar compuestos triacinicos antialergi-cos
DK387480A (da) Fremgangsmaade til fremstilling af 2-alkyl-eller 2-aryithiomethylphenoler
DK154136C (da) Analogifremgangsmaade til fremstilling af 2-amino-3-benzoylphenylacetamider
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK155780A (da) Fremgangsmaade til fremstilling af peptider
DK177680A (da) Fremgangsmaade til fremstilling af 7-n-heterocyclyl-cephalosporiner
DK355180A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK134880A (da) Fremgangsmaade til fremstilling af benzothiazolderivater fremgangsmaade til fe
DK157850C (da) Fremgangsmaade til fremstilling af 7-acylindolin-2-oner
DK456580A (da) Fremgangsmaade til fremstilling af bicycliske beta-lactamringholdige forbindelser
DK392879A (da) Fremgangsmaade til fremstilling af 3-karbamouloxymetylcephalosorinforbindelser
DK239080A (da) Fremgangsmaade til modificering af azopigmenter
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin

Legal Events

Date Code Title Description
PBP Patent lapsed